10th March 2023: We are pleased to share that the TFA Advisory Group Quarterly Review Meeting for quarter 1  of the current year was successfully held at the Heartfile office. The gathering took place on. The core committee TFA Advisory Group attended the meeting to discuss key matters pertaining to Trans Fatty Acids elimination in Pakistan. The meeting focused on reviewing the progress made during the previous quarter, assessing the strategies, and identifying areas for improvement to achieve our collective objective of eliminating iTFA from the Pakistan food chain.

23rd of May 2023: We are pleased to share that the TFA Advisory Group Quarterly Review Meeting for the second quarter of the current year was successfully held at the Heartfile office. This important gathering took place on the The core committee of the TFA Advisory Group came together to address critical matters concerning the elimination of Trans Fatty Acids (TFA) in Pakistan.

The primary objective of the meeting was to discuss the draft report of the recently completed chemical analyses of iTFA content in food samples. These analyses were conducted with the support of Heartfile by PCSIR, which has recently been upgraded for this purpose. The findings presented in the report played a significant role in shaping our strategies and advocacy efforts and actions needed toward eradicating industrially produced Trans Fatty Acids from the food chain in Pakistan.

We remain committed to our collective aim of eliminating Trans Fatty Acids from the food chain in Pakistan by 2023, and the discussions during the meeting served as a crucial step in achieving this goal. 

23rd May 2023: Heartfile, a renowned research institution committed to improving healthcare systems, is pleased to announce the publication of its comprehensive cost-effectiveness analysis for the elimination of industrially produced Trans Fatty Acids from the Pakistan food chain. The study sheds light on the economic implications and benefits of ITFA elimination efforts, providing valuable insights for policymakers, healthcare professionals, and stakeholders.  It underscores the importance of sustained investment in ITFA elimination programs to achieve significant health and economic benefits. 

The analysis employed a rigorous methodology, incorporating extensive data collection, modeling, and statistical analysis, and assessed the cost of implementing the interventions against the potential health benefits and monetary savings resulting from reduced disease burden and associated healthcare costs.

The study, titled “Heartfile Cost Effectiveness Analysis for ITFA Elimination in Pakistan,” is available for public access and can be accessed through Heartfile’s official website at  http://www.heartfile.org/wp-content/uploads/2023/05/TFA-cost-effectiveness-study-Pakistan-FINAL-02052023.docx